Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava
Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human
 trial to evaluate the efficacy and safety of Ecklonia cava extract on hyperlipidemia.
The investigators performed a 12-week, randomized, double-blind, placebo-controlled human
 trial to evaluate the efficacy and safety of Ecklonia cava extract on hyperlipidemia. The
 investigators measured improvement of lipid profile, including total cholesterol,
 triglyceride, HDL-cholesterol, and LDL-cholesterol.
Inclusion Criteria:

 -  Mild hypercholesterolemic subjects(≥200mg/dL of total cholesterol or ≥110mg/dL of
 LDL-cholesterol)

 Exclusion Criteria:

 -  Self-reported pregnancy, lactation

 -  Prevalent heart disease, cancer, renal disorder, or diabetes mellitus, and use of
 lipid-lowering drugs